Literature DB >> 31940133

Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: a 4-year cohort study in China.

Xin-Yao Liu1, Qiao-Yu Wu1, Zhi-Heng Chen2, Guang-Yu Yan1, Yao Lu3,4, Hai-Jiang Dai1, Ying Li2, Ping-Ting Yang2, Hong Yuan5,6,7.   

Abstract

PURPOSE: Previous studies revealed that high serum uric acid (SUA) levels correlated with increased triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio. However, evidence is lacking regarding whether TG/HDL-C is an independent risk factor or just a simple marker of hyperuricemia. We aimed to investigate the relationship between TG/HDL-C and the risk of hyperuricemia in Chinese population.
METHODS: This retrospective cohort study involved 15,198 subjects (43.14 ± 13.13 years, 54.9% men) who were free of hyperuricemia at baseline. The association between TG/HDL-C and the risk of hyperuricemia, in the total sample and stratified by subgroups, was examined by multiple logistic regression analyses.
RESULTS: During 4 years follow-up, hyperuricemia occurred in 2365 (15.6%) participants. The cumulative incidence of hyperuricemia was significantly elevated with increasing TG/HDL-C quartiles (5.9, 10.8, 18.4, and 27.5%, respectively). After multivariate adjustment, the odds ratio for hyperuricemia in the highest compared with the lowest quartile of TG/HDL-C was 1.80 (95% confidence interval [CI] 1.49, 2.18), and each SD increment of TG/HDL-C ratio caused a 10% additional risk for hyperuricemia. Moreover, subgroup analyses showed that the association between TG/HDL-C and the risk of hyperuricemia was more pronounced in women and normal-weight adults. The results were consistent when analyses were restricted to participants without metabolic syndrome.
CONCLUSIONS: TG/HDL-C ratio was positively related to the risk of hyperuricemia in Chinese population, particularly in women and normal-weight individuals. These findings suggested the potential of TG/HDL-C ratio to serve as an independent risk indicator in the prevention of hyperuricemia.

Entities:  

Keywords:  High-density lipoprotein cholesterol; Hyperuricemia; Insulin resistance; Triglyceride

Mesh:

Substances:

Year:  2020        PMID: 31940133     DOI: 10.1007/s12020-019-02176-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  50 in total

Review 1.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 2.  Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.

Authors:  Karn Wijarnpreecha; Panadeekarn Panjawatanan; Natasorn Lekuthai; Charat Thongprayoon; Wisit Cheungpasitporn; Patompong Ungprasert
Journal:  Liver Int       Date:  2016-12-31       Impact factor: 5.828

3.  Hyperuricemia and gout are associated with cancer incidence and mortality: A meta-analysis based on cohort studies.

Authors:  Yuxiu Xie; Peng Xu; Kang Liu; Shuai Lin; Meng Wang; Tian Tian; Cong Dai; Yujiao Deng; Na Li; Qian Hao; Linghui Zhou; Zhijun Dai; Hui Guo
Journal:  J Cell Physiol       Date:  2019-01-28       Impact factor: 6.384

4.  Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016.

Authors:  Michael Chen-Xu; Chio Yokose; Sharan K Rai; Michael H Pillinger; Hyon K Choi
Journal:  Arthritis Rheumatol       Date:  2019-04-15       Impact factor: 10.995

Review 5.  Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases.

Authors:  Hongsha Wang; Haifeng Zhang; Lin Sun; Weiying Guo
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

6.  Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese.

Authors:  Tiange Wang; Yufang Bi; Min Xu; Yun Huang; Yu Xu; Xiaoying Li; Weiqing Wang; Guang Ning
Journal:  Endocrine       Date:  2011-03-23       Impact factor: 3.633

7.  Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.

Authors:  Zhimin Miao; Changgui Li; Ying Chen; Shihua Zhao; Yangang Wang; Zhongchao Wang; Xinyan Chen; Feng Xu; Fang Wang; Ruixia Sun; Jianxia Hu; Wei Song; Shengli Yan; Cong-Yi Wang
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

8.  Relationship between hyperuricemia and lipid profiles in US adults.

Authors:  Tao-Chun Peng; Chung-Ching Wang; Tung-Wei Kao; James Yi-Hsin Chan; Ya-Hui Yang; Yaw-Wen Chang; Wei-Liang Chen
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

Review 9.  Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.

Authors:  Thomas Bardin; Pascal Richette
Journal:  BMC Med       Date:  2017-07-03       Impact factor: 8.775

Review 10.  Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis.

Authors:  Rui Liu; Cheng Han; Di Wu; Xinghai Xia; Jianqiu Gu; Haixia Guan; Zhongyan Shan; Weiping Teng
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

View more
  4 in total

1.  Association Between the Cardiometabolic Index and Hyperuricemia in an Asymptomatic Population with Normal Body Mass Index.

Authors:  Yu-Qiang Zuo; Zhi-Hong Gao; Yu-Ling Yin; Xu Yang; Ping-Yong Feng
Journal:  Int J Gen Med       Date:  2021-11-23

2.  Associations of Triglyceride-Glucose Index and Its Derivatives with Hyperuricemia Risk: A Cohort Study in Chinese General Population.

Authors:  Qing Gu; Xue Hu; Jian Meng; Jun Ge; Sui Jun Wang; Xing Zhen Liu
Journal:  Int J Endocrinol       Date:  2020-09-17       Impact factor: 3.257

3.  Prevalence of hyperuricemia in patients with severe obesity and the relationship between serum uric acid and severe obesity: A decade retrospective cross-section study in Chinese adults.

Authors:  Chonin Cheang; Saikam Law; Jieru Ren; Wengtong Chan; Cunchuan Wang; Zhiyong Dong
Journal:  Front Public Health       Date:  2022-08-26

4.  A cohort study on risk factors of high-density lipoprotein cholesterol hypolipidemia among urban Chinese adults.

Authors:  Fang Tang; Jian Wang; Stephen Nicholas; Dongfu Qian; Rugang Liu
Journal:  Lipids Health Dis       Date:  2021-02-22       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.